Overview
Maximo Hernandez-Sanz practices practicing medicine in London, United Kingdom.
His clinical expertise encompasses Creutzfeldt-Jakob Disease and Hairy Cell Leukemia (HCL).
He is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Maximo Hernandez-Sanz
Is Maximo Hernandez-Sanz a top-rated expert for Creutzfeldt-Jakob Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Maximo Hernandez-Sanz is classified as an Experienced expert for Creutzfeldt-Jakob Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Maximo Hernandez-Sanz participate in research or clinical trials?
Yes. Maximo Hernandez-Sanz has published 14 articles and abstracts on conditions like Creutzfeldt-Jakob Disease. You can view a list of Maximo Hernandez-Sanz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Creutzfeldt-Jakob DiseaseMr. Hernandez-Sanz isExperienced. Learn about Creutzfeldt-Jakob Disease.
- Hairy Cell Leukemia (HCL)Mr. Hernandez-Sanz isExperienced. Learn about Hairy Cell Leukemia (HCL).